Ultraviolet A and melanoma: A review

Journal of the American Academy of Dermatology

Volumn 44, Issue 5, 2001, Pages 837-846

  Wang, Steven Q ^a   Setlow, Richard ^b   Berwick, Marianne ^c   Polsky, David ^a   Marghoob, Ashfaq A ^c,d   Kopf, Alfred W ^a   Bart, Robert S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c Memorial Sloan Kettering Hospital   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; OXYGEN RADICAL; PSORALEN; SUNSCREEN;

ANIMAL MODEL; CANCER INCIDENCE; CANCER MORTALITY; CELL CULTURE; DNA DAMAGE; EPIDEMIOLOGICAL DATA; FLUORESCENT LIGHTING; GENE MUTATION; HUMAN; IMMUNE DEFICIENCY; LENTIGO; MELANOMA; NONHUMAN; PHOTOSENSITIZATION; PRIORITY JOURNAL; PUVA; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; REVIEW; SUNBURN; ULTRAVIOLET A RADIATION;

EID: 0035029551     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.114594     Document Type: Article

References (106)

1. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
2. Update on the incidence and mortality from melanoma in the United States
3. An analysis of UVA emissions from sunlamps and the potential importance for melanoma
4. Mutagenic effects per erythemal dose of artificial and natural sources of ultraviolet light
5. Photoprotection by melanin: A comparison of black and Caucasian skin
6. Transmission of UV-radiation through human epidermal layers as a factor influencing the minimal erythema dose
7. Reduction of ultraviolet transmission through fabrics used in the manufacture of summer wear: Clinical implications
8. A reference action spectrum for ultraviolet induced erythema in human skin
9. An ultraviolet radiation action spectrum for immediate pigment darkening
10. Immediate pigment darkening: Visual and reflectance spectrophotometric analysis of action spectrum
11. Persistent pigment darkening response as a method for evaluation of ultraviolet A protection assays
12. Rising trends in melanoma: An hypothesis concerning sunscreen effectiveness
13. Wavelengths effective in induction of malignant melanoma
14. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion
15. The molecular pathways of ultraviolet-induced carcinogenesis
16. Mutations in cancer genes of UV-induced skin tumors of hairless mice
17. Molecular mechanisms of ultraviolet radiation carcinogenesis
18. Comparison of initial yields of DNA-to-protein crosslinks and single-strand breaks induced in cultured human cells by far- and near-ultraviolet light, blue light and X-rays
19. Prooxidant states and tumor promotion
20. UVA1 radiation triggers two different final apoptotic pathways
21. The cytotoxic and mutagenic effects of UVA radiation on L5178Y mouse lymphoma cells
22. Cytotoxicity and genotoxicity of UVA irradiation in Chinese hamster ovary cells measured by specific locus mutations, sister chromatid exchanges and chromosome aberrations
23. Mutagenesis and cytotoxicity in human epithelial cells by far- and near-ultraviolet radiations: Action spectra
24. Action spectra for killing and mutation of Chinese hamster cells exposed to mid- and near-ultraviolet monochromatic light
25. The wavelength dependence of u.v.-induced pyrimidine dimer formation, cell killing and mutation induction in human diploid skin fibroblasts
26. (Pheo)melanin photosensitizes UVA-induced DNA damage in cultured human melanocytes
27. Induction of oxidative DNA base damage in human skin cells by UV and near visible radiation
28. A role for ultraviolet A in solar mutagenesis
29. The human melanocyte as a particular target for UVA radiation and an endpoint for photoprotection assessment
30. Development and validation of the in vivo alkaline comet assay for detecting genomic damage in marine flatfish
31. Hypersensitivity of human lymphocytes to UV-B and solar irradiation
32. Use of the alkaline comet assay to detect DNA repair deficiencies in human fibroblasts exposed to UVC, UVB, UVA and gamma-rays
33. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light
34. Ultraviolet radiation A-induced precursors of cutaneous melanoma in Monodelphis domestica
35. Sunlight and carcinogenesis: Expression of p53 and pyfimidine dimers in human skin following UVA I, UVA I + II and solar simulating radiations
36. Low-dose ultraviolet-B irradiation depletes human epidermal Langerhans cells
37. Immunological effects of solarium exposure
38. Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content
39. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes: An essential role for keratinocyte-derived IL-10
40. Interferon gamma inhibits interleukin 10 production by monocytes
41. UVA-induced immune suppression through an oxidative pathway
42. Chronic low-dose UVA irradiation induces local suppression of contact hypersensitivity, Langerhans cell depletion and suppressor cell activation in C3H/HeJ mice
43. Ultraviolet A radiation (320-400 nm) protects hairless mice from immunosuppression induced by ultraviolet B radiation (280-320 nm) or cis-urocanic acid
44. Low-dose UVA and UVB have different time courses for suppression of contact hyper-sensitivity to a recall antigen in humans
45. UVA II exposure of human skin results in decreased immunization capacity, increased induction of tolerance and a unique pattern of epidermal antigen-presenting cell alteration
46. Improved protection against solar-simulated radiationinduced immunosuppression by a sunscreen with enhanced ultraviolet A protection
47. Local and systemic effect of ultraviolet irradiation (UVB and UVA) on human allergic contact dermatitis
48. Immunobiology and immunotherapy of melanoma
49. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
50. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
51. Melanoma in children
52. Cutaneous malignant melanoma after Hodgkin's disease
53. Malignant melanoma in renal-transplant recipients
54. Aggressive cutaneous malignancies following cardiothoracic transplantation: The Australian experience
55. Do tanning lamps cause melanoma? An epidemiologic assessment
56. Indoor tanning: Risks, benefits, and future trends
57. Artificial suntanning: Spectral irradiance and hazard evaluation of ultraviolet sources
58. Natural UV-8 radiation received by people with outdoor, indoor, and mixed occupations and UV-B treatment of psoriasis
59. Sunlamp use and the risk of cutaneous malignant melanoma: A population-based case-control study in Connecticut, USA
60. Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: Results of a case-control study in Ontario, Canada
61. Risk of cutaneous malignant melanoma in relation to use of sunbeds: Further evidence for UV-A carcinogenicity
62. Tanning with UVB or UVA: An appraisal of risks
63. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): The PUVA follow-up study
64. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits
65. Risk factors for the development of malignant melanoma-I: Review of case-control studies
66. High sun protection factor sunscreens in the suppression of actinic neoplasia
67. Reduction of solar keratoses by regular sunscreen use
68. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: A randomised controlled trial
69. Some environmental and bodily characteristics of melanoma patients: A case-control study
70. An inquiry into the epidemiology of melanoma
71. Malignant melanoma: Aetiological importance of individual pigmentation and sun exposure
72. Melanoma and use of sunscreens: An EORTC case-control study in Germany, Belgium and France
73. Is the use of sunscreens a risk factor for malignant melanoma?
74. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: An Austrian case-control study
75. The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure
76. More about: Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children
77. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light
78. Sun exposure, pigmentary traits, and risk of cuta- neous malignant melanoma: A case-control study in a Mediterranean population
79. Cutaneous malignant melanoma and sun exposure in Spain
80. Sunscreen use and duration of sun exposure: A double-blind, randomized trial
81. Determination of UVA protection factors by means of immediate pigment darkening in normal skin
82. Could sunscreens increase melanoma risk?
83. Re: Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice
84. Malignant melanoma and exposure to fluorescent lighting at work
85. Relationship of fluorescent lights to malignant melanoma: Another view
86. The aetiological significance of sunlight and fluorescent lighting in malignant melanoma: A case-control study
87. Cutaneous malignant melanoma and fluorescent lighting
88. Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma
89. Phototherapy and photochemotherapy: An update
90. The PUVA-induced pigmented macule: A lentiginous proliferation of large, sometimes cytologically atypical, melanocytes
91. Ultrastructure of poikilodermalike pigmentary changes after repeated experimental PUVA-overdosage
92. Psoralens and UV-A-induced stellate hyperpigmented freckling
93. Auftretan disseminierter hyperpigmentierter frecke unter PUVA-behandlung
94. Melanocyte changes following PUVA therapy
95. Psoralen-UVA-treated psoriatic lesions: Ultrastructural changes
96. PUVA-induced melanocytic atypia: Is it confined to PUVA lentigines?
97. Freckles induced by PUVA treatment
98. Cutaneous and ocular side-effects of oral photochemotherapy: Results of an 8-year follow-up study
99. Possible ultraviolet A-induced lentigines: A side effect of chronic tanning salon usage
100. UVA-induced melanocytic lesions
101. DNA repair processes protect human beings from premature solar skin damage: Evidence from studies on xeroderma pigmentosum
102. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis
103. PUVA and cancer risk: The Swedish follow-up study
104. Erythema, skin cancer risk, and sunscreens
105. Sunscreens for delay of ultraviolet induction of skin tumors
106. Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation